Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2014

Choline kinase beta is required for normal endochondral bone
formation
Zhuo Li
University of Alberta

Gengshu Wu
University of Alberta

Roger B. Sher
University of Maine

Zohreh Khavandgar
Université McGill

Martin Hermansson
University of Alberta

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub
Part of the Pediatrics Commons

Citation of this paper:
Li, Zhuo; Wu, Gengshu; Sher, Roger B.; Khavandgar, Zohreh; Hermansson, Martin; Cox, Gregory A.;
Doschak, Michael R.; Murshed, Monzur; Beier, Frank; and Vance, Dennis E., "Choline kinase beta is required
for normal endochondral bone formation" (2014). Paediatrics Publications. 769.
https://ir.lib.uwo.ca/paedpub/769

Authors
Zhuo Li, Gengshu Wu, Roger B. Sher, Zohreh Khavandgar, Martin Hermansson, Gregory A. Cox, Michael R.
Doschak, Monzur Murshed, Frank Beier, and Dennis E. Vance

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/769

NIH Public Access
Author Manuscript
Biochim Biophys Acta. Author manuscript; available in PMC 2015 July 01.

NIH-PA Author Manuscript

Published in final edited form as:
Biochim Biophys Acta. 2014 July ; 1840(7): 2112–2122. doi:10.1016/j.bbagen.2014.03.008.

Choline kinase beta is required for normal endochondral bone
formation
Zhuo Lia, Gengshu Wua, Roger B. Sherb, Zohreh Khavandgarc, Martin Hermanssona,
Gregory A. Coxd, Michael R. Doschake, Monzur Murshedc,f, Frank Beierg, and Dennis E.
Vancea
aGroup

on the Molecular and Cell Biology of Lipids and Department of Biochemistry, University of
Alberta, Edmonton, Alberta T6G 2S2 Canada

bUniversity
cFaculty

NIH-PA Author Manuscript

dThe

of Maine, Orono, ME USA

of Dentistry, McGill University, Montreal, Quebec, Canada

Jackson Laboratory, Bar Harbor, Maine, USA

eFaculty

of Pharmacy & Pharmaceutical Sciences, University of Alberta, Canada

fDepartment

of Medicine, McGill University, Montreal, Quebec, Canada

gDepartment

of Physiology and Pharmacology, Schulich School of Medicine and Dentistry
University of Western Ontario, London, Ontario, Canada

Abstract
Background—Choline kinase has three isoforms encoded by the genes Chka and Chkb.
Inactivation of Chka in mice results in embryonic lethality, whereas Chkb−/− mice display
neonatal forelimb bone deformations.
Methods—To understand the mechanisms underlying the bone deformations, we compared the
biology and biochemistry of bone formation from embryonic to young adult wild-type (WT) and
Chkb−/− mice.
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Results—The deformations are specific to the radius and ulna during the late embryonic stage.
The radius and ulna of Chkb−/− mice display expanded hypertrophic zones, unorganized
proliferative columns in their growth plates, and delayed formation of primary ossification centers.
The differentiation of chondrocytes of Chkb−/− mice was impaired, as was chondrocyte
proliferation and expression of matrix metalloproteinases 9 and 13. In chondrocytes from Chkb−/−
mice, phosphatidylcholine was slightly lower than in WT mice whereas the amount of
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phosphocholine was decreased by approximately 75%. In addition, the radius and ulna from
Chkb−/− mice contained fewer osteoclasts along the cartilage/bone interface.
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Conclusions—Chkb has a critical role in the normal embryogenic formation of the radius and
ulna in mice.
Keywords
choline kinase; endochondral bone formation; growth plate; chondrocyte; radius; ulna;
phosphocholine

1. Introduction
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Choline kinase (CK) catalyzes the first reaction of the CDP-choline pathway, also known as
the Kennedy pathway, for synthesis of phosphatidylcholine (PC), one of the major
phospholipids in cellular membranes [1,2]. CK is a cytosolic enzyme, present in all tissues
and converts choline to phosphocholine (PCho) [3]. CK exists in three isoforms in mice:
CKα1 and CKα2 encoded by the Chka gene, and CKβ encoded by the Chkb gene. Active
CK consists of either homo- or hetero-dimeric forms; neither isoform is active in its
monomeric form [4].
Previous work demonstrated that Chka null mice die very early during embryonic
development, indicating the importance of CK for embryonic development [5]. In 2006,
mice with a spontaneous 1.6 kb intragenic deletion within the Chkb gene were identified [6].
The Chkb−/− mice have a rostral-to-caudal gradient of severity with minor forelimb but
severe hindlimb muscular dystrophy. Previous work has shown that mitochondrial
dysfunction contributes to the muscular dystrophy phenotype in Chkb−/− mice [7]. Chkb−/−
mice also display striking bone deformation in the forelimb. However, the reason for the
forelimb bone deformity had not been investigated.
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The limb long bones form by endochondral ossification, during which a cartilage template is
first formed and is subsequently replaced by bone tissue [8–12]. Endochondral bone
formation begins with mesenchymal cell condensation that pre-figures the future shape of
the bones. The cells in these mesenchymal condensations differentiate into chondrocytes, the
major cell type in cartilage. This differentiation process is mainly regulated by the
transcription factor Sox9 [13,14]. The chondrocytes then undergo proliferation that results in
parallel columns of dividing cells. These dividing cells assume a flattened shape and form
columns that resemble stacks of coins with a distinct orientation. The cells then stop
dividing, exit from the cell cycle, increase in size and become mature and hypertrophic. The
hypertrophic chondrocytes secrete a specialized extracellular matrix (ECM) which is
eventually remodeled and digested by proteases. Two essential matrix metalloproteinases
(MMPs), MMP9 and MMP13, are involved in the degradation of cartilage ECM [15–17].
Matrix degradation can facilitate the recruitment of blood vessels, as well as osteoblast and
osteoclast cells to invade the hypertrophic cartilage for replacing it with mineralized bone
tissue [18,19]. As bone enlarges further, a so-called secondary ossification center is
established by a similar mechanism at the two ends of the bones. The cartilage structure
between the two ossification centers is known as the growth plate. The growth plate consists
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of distinct layers including the resting zone, proliferation zone and hypertrophic zone, and
the longitudinal endochondral bone growth is primarily controlled by the growth plate
activity [20,21].
In this study, we have demonstrated that Chkb plays an important role in endochondral bone
formation and growth plate physiology. The endochondral bone formation defects and
growth plate phenotypes of Chkb−/− mice significantly contribute to the forelimb bone
deformity.

2. Materials and methods
2.1. Mouse breeding and genotyping
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Chkb−/− mice in C57BL/6J background were originally generated at the Jackson Laboratory
(Bar Harbor, Maine, USA) [6]. All animal procedures were approved by the University of
Alberta’s Institutional Animal Care Committee in accordance with guidelines of the
Canadian Council on Animal Care. WT littermates were used as controls. Heterozygous
mice were bred with each other so that litters and embryos of three genotypes were obtained.
PCR genotyping was performed using DNA from digested tail samples. Two separate
genotyping programs were used to amplify both the WT Chkb allele between exons 5 and 9
and the truncated Chkb allele between exons 3 and 11. The mutation identified in Chkb−/−
mice is a 1.6 kb genomic deletion between exon 3 and intron 9 [6]. The primers used for
genotyping were purchased from Integrated DNA Technologies (Coralville, IA, USA) and
the sequences are included in Supplementary Table 1.
2.2. Skeletal stains and Micro-CT imaging
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For staining of neonatal mouse skeleton and embryonic limb bones by Alizarin Red and
Alcian Blue, the tissues were fixed overnight in 95% ethanol followed by overnight fixation
in acetone. The tissues were then placed in staining solution for one week (0.05% Alizarin
Red, 0.015% Alcian Blue, 5% acetic acid in 70% ethanol). The excess stain was cleared by
treatment with 2% KOH followed by 1% KOH. Images of stained bones were obtained with
an Olympus SP-57OUZ camera. The lengths of limb bones were measured in four littermate
pairs using a dissecting microscope with a ruler. For Micro-CT imaging, intact mice and
mouse forelimbs were scanned by Micro-CT (Skyscan 1076, Kontich, Belgium) at 9 µm
resolution with 100 kV, 100 µA, and power of 10 W. Projected images of the samples were
reconstructed using vendor supplied software (Nrecon 1.6.1.5, SkyScan NV, Kontich,
Belgium).
2.3. Serum biochemistry and tissue-nonspecific alkaline phosphatase (TNAP) assay
Serum calcium level was measured using the QuantiChrom™ calcium assay kit (BioAssay
Systems, Hayward, CA, USA). Insulin-like growth factor 1 (IGF-1) concentration in serum
was measured using an IGF-1 immunoassay kit (R&D Systems, Minneapolis, MN, USA).
Inorganic phosphate levels in serum, cells and tissues were measured by phosphate
colorimetric assay kit (Abcam, Cambridge, MA, USA). Primary chondrocyte cell extracts
were assayed for TNAP activity at 37 °C for 30 min using liquid p-nitrophenyl phosphate as
substrate (Sigma-Aldrich, Oakville, ON, Canada). The colorimetric determination of the
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product (p-nitrophenol) was performed at 405 nm and normalized to the amount of protein
quantified by the Bradford method [22].
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2.4. Histological analysis, tartrate-resistant acid phosphatase (TRAP) staining and
immunohistochemistry
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The long bones from new-born (P0) mice and embryos were dissected and fixed in 4%
paraformaldehyde overnight. The tissues were then embedded in paraffin and 5 µm thick
sections were prepared. Sections were de-waxed in xylene followed by graded dilutions of
ethanol (100% twice, 95% once and 70% once) and finally water. For Safranin-O/fast green
staining, tissue sections were stained in 0.01% fast green for 30 min, dipped in 1% acetic
acid solution, then stained in 0.1% Safranin-O for 5 min. For von Kossa and van Gieson
staining, the sections were stained in 1% silver nitrate solution, washed in distilled water,
treated with 5% sodium thiosulfate, washed in tap water and finally van Gieson stain was
applied. Tissue sections were dehydrated and coverslips were mounted using a xylene-based
mounting solution. Growth plate morphology was examined with a Leica DMRA2
microscope equipped with a Retiga EX camera. The lengths of the hypertrophic zone and
the whole growth plate were measured using OpenLab 4.0.4 software [23–25], and the ratio
of the length of hypertrophic zone: the length of growth plate was calculated.
For immunohistochemistry, sections were incubated in 3% H2O2 for 15 min at room
temperature, followed by antigen retrieval by incubation in 0.1% Triton X-100 for 13 min,
followed by blocking with 5% goat or rabbit serum in phosphate-buffered saline. Sections
were incubated with primary antibodies overnight at 4°C after which secondary antibodies
were applied according to manufacturers’ recommendations. Primary antibodies were: goat
polyclonal anti-human Sox9 (AF3075, R&D Systems, Minneapolis, MN, USA) and mouse
monoclonal anti-mouse proliferating cell nuclear antigen (PCNA) (2586S, Cell Signaling,
Danvers, MA, USA). Incubation with horseradish peroxidase-conjugated secondary
antibody (Abcam, Cambridge, MA, USA) was followed by colorimetric detection with the
substrate diaminobenzidine (DAB) (Dako Canada Inc., Burlington, ON, Canada) Three
independent stainings were performed and representative images are shown.
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For TRAP staining, bone tissue sections from 7-day-old (P7) mice were stained to assess
osteoclast numbers using a leukocyte acid phosphatase kit (Sigma-Aldrich, Oakville, ON,
Canada). The staining was quantified by counting the number of positive foci along the
chondro-osseous junction.
2.5. Primary culture of chondrocytes
Primary chondrocytes were prepared from long bones of embryonic 15.5-day-old (E15.5)
mouse embryos, as previously described [26]. Briefly, the long bones were dissected and
incubated at 37°C for 15 min in 0.25% trypsin-EDTA, followed by digestion at 37°C with 3
mg/ml collagenase P for 2 h in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum (FBS). The cell suspensions were filtered through a 40 mm cell
strainer (Fisher Scientific, Ottawa, ON, Canada), washed, counted and plated at 37°C in 6well plates with media containing 2:3 DMEM:F12, 10% FBS, 0.5 mM L-glutamine, and
penicillin/streptomycin (25 units/ml).
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2.6. RNA isolation and quantitative real-time PCR analysis
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RNA was isolated directly from either E15.5 embryonic bones or primary chondrocytes. For
embryonic bones, E15.5 radius and ulna were dissected free from connective tissue. The
bones were then placed into RNA stabilization reagent (Qiagen, Mississauga, ON, Canada)
and passed through a series of syringes with 21G, 23G and 25G needles (BD Biosciences,
Mississauga, ON, Canada) to break the tissues. The RNA in the homogenate was purified
with RNeasy Micro Kit according to the manufacturer’s instructions (Qiagen, Mississauga,
ON, Canada). For primary chondrocytes, RNA was isolated using TRIzol reagent, then
reverse-transcribed by oligo (dT) and Superscript II reverse transcriptase (Invitrogen,
Burlington, ON, Canada). Quantitative real-time PCR was performed using a Rotor-Gene
3000 instrument and data were analyzed using the Rotor-Gene 6.0.19 software (Montreal
Biotech, Dorval, QC, Canada). Cyclophilin mRNA was used to normalize gene expression.
The primers (Supplementary Table 1) were purchased from Integrated DNA Technologies
(Coralville, IA, USA).
2.7. Immunoblot analyses and choline kinase assay
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For immunoblotting, primary chondrocyte cells were harvested in buffer containing 10 mM
Tris-HCl (pH 7.2), 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride and a protease inhibitor cocktail (1:100 dilution, P8340,
Sigma-Aldrich, Oakville, ON, Canada). The cell extracts were centrifuged at 348,000 × g
for 15 min at 4° C. The protein content of the supernatant (cytosol) was quantified by the
Bradford procedure [22]. Proteins (50 µg/lane) were separated by electrophoresis on 10%
polyacrylamide gels containing 0.1% SDS, and immunoblotted with the relevant primary
antibodies. The following antibodies were used: rabbit polyclonal anti-mouse CKβ (dilution
1:1000; a gift from Dr. K. Ishidate, Teikyo Heisei University, Japan) and mouse monoclonal
anti-rat Phospho1 (dilution 1:500, ab90581, Abcam, Cambridge, MA, USA). Antibodies
raised against either α-tubulin or β-actin (Abcam, Cambridge, MA, USA) were used for
loading controls.
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Total CK activity was determined in the cytosolic fraction as described [27], with minor
modifications. Briefly, the supernatants were incubated in a final volume of 100 µl buffer
containing 0.1 M Tris-HCl, pH 8.75, 10 mM ATP, 15 mM MgCl2, and 0.25 mM [3H]
choline chloride (10.5 µCi/ml) at 37 °C for 30 min. The product PCho was separated using
an AG1-X8 (200–400 mesh, OH- form) column (Bio-Rad, Mississauga, ON, Canada).
2.8. Gelatin zymography
To determine MMP9 activity, primary chondrocyte cells were harvested in MMP lysis
buffer (120 mM Tris, 0.1% Triton X-100, 0.01% NaN3, 5% glycerol at pH 8.7). Proteins (10
µg/lane) were electrophoresed on SDS-polyacrylamide gels co-polymerized with gelatin (2
mg/ml). Distilled water and 20 µg proteins from the chondrogenic cell line ATDC5 (SigmaAldrich, Oakville, ON, Canada) were loaded onto the gel as negative and positive controls,
respectively. Following electrophoresis, the gel was washed 4 times with 2.5% Triton X-100
for 15 min. MMP9 activity was developed by incubating the gel overnight at 37 °C in
incubation buffer (50 mM Tris, 5 mM CaCl2, 0.15 M NaCl, 0.5 mM NaN3, pH 7.6) after
which the gel was stained with Coomassie blue.
Biochim Biophys Acta. Author manuscript; available in PMC 2015 July 01.
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2.9. Mass-spectrometric analysis of lipids and water-soluble choline metabolites
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Lipids were extracted from primary chondrocytes (100 µg protein) according to the method
described in [28]. Phospholipid internal standards were used for quantification of the lipid
species and were added at the stage of lipid extraction. The lipids were quantified using
liquid chromatography-mass spectrometry (LC-MS) as described [29]. The acyl residues of
the lipid species were quantified using fragmentation analysis [30]. The water-soluble
choline metabolites were analyzed by LC-MS/MS as described previously [31].
2.10. Statistical analysis
All statistical analyses were performed using GraphPad Prism software 6.0. Data are mean
values ± standard error of the mean (SEM). Statistical significance of differences (P < 0.05)
was determined by the student’s t test.

3. Results
3.1. Deformation of the radius and ulna in Chkb−/− mice
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Fig. 1A shows the striking outward forelimb bone deformation of 7-day-old (P7) Chkb−/−
mice. The forelimb bone deformation phenotype was also observed in newborn mice, and an
initial characterization of this phenotype has been described [6]. To further characterize the
forelimb bone deformity, the whole body and forelimbs of newborn (P0) Chkb−/− mice and
WT littermates were stained with Alizarin Red & Alcian Blue and viewed by Micro-CT
imaging. No gross skeletal abnormalities were observed except for the obvious deformations
of the radius and ulna of the forelimb (Figs. 1B, C, D and E). No deformity of other limb
long bones, including the humerus of the forelimb, was observed (Figs. 1C and 2C). To
determine if the neonatal bone deformity persisted throughout the postnatal stage, the radius
and ulna of 30-day-old (P30) mice were scanned by Micro-CT. The reconstructed image
shows that the bone deformations in Chkb−/− mice become more severe over time and that
the radius and ulna are curved almost to 90 degrees (Fig. 1F). Together, our observations
revealed that the forelimb bone deformations in Chkb−/− mice are restricted to the radius
and ulna and the deformities become more severe at later stages of development.
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3.2. The radius and ulna in Chkb−/− mice are shorter than in WT mice and are deformed
during embryonic development
To further characterize the limb long bones, the radius, ulna and humerus from the forelimb,
and the tibia and femur from the hindlimb, of newborn mice were stained with Alizarin Red
and Alcian Blue. In addition to the deformities, the lengths of the radius and ulna in neonatal
Chkb−/− mice were significantly shorter than in WT mice, whereas the lengths of the
humerus, tibia and femur were not different (Figs. 2A, C). However, in 21-day-old (P21)
Chkb−/− mice, the humerus, tibia and femur were slightly shorter than in WT mice while the
lengths of the radius and ulna were dramatically reduced (Supplementary Fig. 1C).
Interestingly, the growth of Chkb−/− mice was also retarded, and these mice gained
significantly less body weight before weaning (Supplementary Figs. 1A, B). The level of
IGF-1, an important regulator of postnatal skeletal development [32,33], was approximately
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50% lower in Chkb−/− mice than in WT mice (Supplementary Fig. 1D), which might
contribute to the growth retardation.
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The deformities of the radius and ulna in Chkb−/− mice are evident at birth, raising the
possibility that their deformations occur during embryonic development. We, therefore,
isolated and stained the forelimbs from E13.5 to E17.5 mice and observed deformations of
the radius and ulna of Chkb−/− mice during late embryonic development (by E17.5) (Fig.
2B). The radius and ulna in Chkb−/− mice were shorter than in WT littermates as early as the
E14.5 stage (Fig. 2B), suggesting that Chkb−/− mice have defects in embryonic cartilage
development and that the bone shortening precedes the deformity.
3.3. The radius and ulna in Chkb−/− mice have growth plate defects
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The presence of shorter embryonic and neonatal radius and ulna in the Chkb−/− mice
suggests that the biology of their growth plates might be abnormal. Therefore, we studied
the growth plate organization of the radius and ulna in P0 and E16.5 mice by Safranin O/fast
green staining. Figure 3 shows representative images and quantification of the staining. The
staining clearly shows that both the radius and ulna of Chkb−/− mice contain expanded
hypertrophic zones (Figs. 3A, B). The ratio of hypertrophic zone length/total growth plate
length also indicates that hypertrophic zones of the Chkb−/− mice are longer and enlarged
compared to those in WT mice (~1.5 fold higher for the radius and ~2-fold higher for the
ulna) (Figs. 3C, D). Moreover, the radius and ulna of E16.5 Chkb−/− mice also contained
disorganized proliferation zones with loss of columnar organization and irregular
chondrocyte morphology (Figs. 3E, F). Together, these observations clearly show that the
radius and ulna of Chkb−/− mice have defects in growth plate development.
3.4. Impaired chondrocyte differentiation and decreased chondrocyte proliferation in the
radius and ulna from Chkb−/− mice
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The growth plate phenotypes observed in the radius and ulna of Chkb−/− mice suggest that
endochondral bone formation is defective. We, therefore, examined chondrocyte
differentiation and proliferation by immunohistochemistry of Sox9 and proliferating cell
nuclear antigen (PCNA) expression in paraffin sections of E15.5 bones. Sox9 is an early
chondrogenic marker that regulates chondrocyte differentiation [13,14]. The growth plates
of both the radius and ulna of Chkb−/− mice exhibited significantly less Sox9 and PCNA
expression than did of WT mice (Figs. 4A, B, D, and E). Quantification of the percentage of
SOX9- and PCNA-expressing cells is shown in Figs. 4G and 4H, respectively. These data
demonstrate that chondrocyte differentiation and proliferation of the radius and ulna are
decreased in Chkb−/− mice. However, chondrocyte differentiation and proliferation of the
humerus appear to be normal since Sox9 and PCNA expression is comparable to that in WT
littermates (Figs. 4C, F, G and H).
3.5. MMP9 and MMP13 expression is impaired in the radius and ulna of Chkb−/− mice
Several MMPs are essential for the cleavage of cartilage ECM and replacement of cartilage
by bone tissue. Loss of specific MMPs, such as MMP9 and MMP13, impairs matrix
degradation and expands the hypertrophic zone in the growth plate [15–17]. Since the
hypertrophic zones in the radius and ulna of Chkb−/− mice were enlarged, we studied
Biochim Biophys Acta. Author manuscript; available in PMC 2015 July 01.
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MMP9 and MMP13. We first performed quantitative real-time PCR gene expression
analysis of the mRNAs encoded by MMP9 and MMP13 and observed significantly lower
levels of MMP9 and MMP13 mRNAs in both embryonic bones and in primary chondrocytes
in the radius and ulna of Chkb−/− mice compared to WT mice (Figs. 5A, B). We also
performed gelatin zymography assays for MMP9 activity using primary chondrocytes
isolated from the radius and ulna of E15.5 mice. MMP9 digests gelatin and exists in two
forms: an uncleaved pro-form and a cleaved mature form [34]. Thus, MMP9 activity can be
visualized as two bands after staining and destaining the gel. This assay showed that
chondrocytes from the radius and ulna of Chkb−/− mice contained markedly less MMP9
activity than did those from WT mice (Fig. 5C). These data suggest that the radius and ulna
from Chkb−/− mice have impaired MMP activity that leads to decreased cartilage ECM
degradation.
3.6. Recruitment of osteoclasts to the chondro-osseous junction in the radius and ulna
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Osteoclasts play an important role in endochondral ossification by cartilage resorption and
the conversion of cartilage matrix to bone matrix [35]. Mice that are deficient in osteoclast
production have enlarged hypertrophic zones in their growth plates [36]. Consequently, we
determined if the growth plate phenotypes observed in Chkb−/− mice were associated with
impaired cartilage resorption by staining P7 radius and ulna bone sections for tartrateresistant acid phosphatase (TRAP). TRAP staining of the radius and ulna of Chkb−/− mice
along the chondro-osseous junction was significantly less than that of the WT mice (Figs.
6A, B, C and D). The number of TRAP-positive foci in the radius and ulna was
approximately 50% less in the Chkb−/− mice than in the WT mice (Figs. 6E, F). These data
suggest that the recruitment of osteoclasts to the cartilage/bone junction is impaired in the
radius and ulna of Chkb−/− mice.
3.7. Primary ossification of the radius and ulna
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The aforementioned endochondral bone formation defects in the radius and ulna of Chkb−/−
mice, including impaired ECM degradation and cartilage resorption, likely lead to delayed
chondrocyte mineralization. We, therefore, determined if cartilage mineralization was
altered by performing von Kossa staining of Chkb−/− and WT mice bone sections from the
radius and ulna of E15.5 mice to examine the formation of primary ossification centers.
Figure 7 shows that the mineralized area in the bone center of both the radius and ulna of
Chkb−/− mice was smaller than in WT mice and that the zone of unmineralized cartilage
was larger. These data indicate that formation of the primary ossification center of the radius
and ulna of Chkb−/− mice is delayed. The enlargement of the hypertrophic zone and delayed
cartilage mineralization are reminiscent of osteomalacia, a disease characterized by impaired
bone mineralization, secondary to reduced plasma calcium levels [37]. However, serum
calcium levels were not lower in Chkb−/− mice compared to WT mice (Supplementary Fig.
3C).
3.8. Biochemical analyses in primary chondrocytes
To confirm that CKβ had indeed been eliminated in the Chkb−/− mice, limb long bones from
E15.5 mice were dissected free of soft tissue, and primary chondrocytes were isolated.
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Immunoblotting confirmed the absence of CKβ in Chkb−/− mice (Fig. 8A). Moreover, total
CK activity was approximately 80% lower in chondrocytes from all major long bones of
Chkb−/− mice compared to WT mice (Fig. 8B). Because CK catalyzes the first step of the
CDP-choline pathway for the synthesis of PC, we quantified the levels of choline
metabolites and the major phospholipids in Chkb−/− and WT chondrocytes. Primary
chondrocytes isolated from the combined radius and ulna, as well as from the humerus, were
used for quantification of amounts of these metabolites by mass spectroscopy. Chondrocytes
from the radius and ulna of Chkb−/− mice contained approximately 75% less PCho than
those from WT mice whereas the amount of choline was not different (Fig. 8C). The amount
of the phospholipid product, PC, was ~10% lower in chondrocytes from Chkb−/− compared
to WT mice; amounts of other phospholipids were unchanged by CKβ deficiency (Fig. 8D).
Similar to chondrocytes from the radius and ulna of Chkb−/− mice, the PCho level in
chondrocytes from the humerus was also ~75% lower (Fig. 8E) whereas the amount of PC
was decreased by only ~10% (Fig. 8F). Thus, the absence of CKβ in Chkb−/− mice only
slightly reduces the amount of PC but significantly decreases PCho production in cartilage.

4. Discussion
NIH-PA Author Manuscript

These data show that the forelimb bone deformations in Chkb−/− mice are limited to the
radius and ulna, and that the deformities occur before birth. Moreover, the radius and ulna of
Chkb−/− mice have abnormal growth plate physiology and endochondral bone formation,
including expanded hypertrophic zones, impaired chondrocyte differentiation and
proliferation, decreased cartilage ECM digestion and osteoclast staining, and delayed
formation of the primary ossification center.
4.1. Deformations of the radius and ulna of Chkb−/− mice are probably not caused by
abnormal limb patterning
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The initial phenotype characterized in Chkb−/− mice was muscular dystrophy; CKβ
mutations have been identified in humans with muscular dystrophy [38]. However, no CKβ
mutations in humans have been associated with bone disease. The radius and ulna
deformations, and the growth retardation phenotype in Chkb−/− mice are reminiscent of
Turner syndrome, Leri-Weill dyschondrosteosis and Langer syndrome in humans, which are
associated with mutations in the short stature homeobox (Shox) gene. These individuals are
characterized by dwarfism, limb shortening and bowed radius/ulna and tibia/fibula [39–41].
However, mice do not express the Shox gene [42] but do have the Shox2 paralog, which is
also expressed in humans [43]. Shox2 deficiency in mice severely affects proximal limb
development including that of the humerus and femur; in contrast, development of the radius
and ulna is normal [44–46]. In Chkb−/− mice, the most prominent defects are in the radius
and ulna. The formation and pattering of limbs are guided by Hox genes. Specific
combinations of mutations in Hox genes result in severely deformed limb elements [47].
The formation and patterning of the radius and ulna are tightly regulated by Hoxa11 and
Hoxd11. Inactivation of murine Hoxa11 and Hoxd11 completely disrupts formation of
radius and ulna of the forelimb [48,49]. To determine if the deformations of the radius and
ulna in Chkb−/− mice were due to altered Hoxa11 and Hoxd11 gene expression, we
performed quantitative real-time PCR analysis of E15.5 embryonic bones and primary
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chondrocytes from Chkb−/− and WT mice but did not detect any differences in expression of
these two genes (Supplementary Fig. 2). This observation suggests that the deformities of
the radius and ulna are probably not caused by abnormal limb patterning. This conclusion is
also supported by the appearance of the deformities during late embryonic development
(Fig. 2B), long after patterning has occurred.
4.2. Radius and ulna of Chkb−/− mice have impaired replacement of cartilage by bone
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The most dramatic phenotypes observed in the growth plates of the radius and ulna from
Chkb−/− mice are expanded hypertrophic zones (Fig. 3) and delayed formation of the
primary ossification center (Fig. 7). These two growth plate defects suggest that CKβ
deficiency impairs the conversion of cartilage to bone tissue. Cartilage matrix degradation
plays an essential role in the replacement of cartilage by bone tissue. Invasion of the
ossification front, including the formation of blood vessels, as well as osteoblast and
osteoclast cells, requires extensive degradation of cartilage ECM surrounding the late
hypertrophic cells. Two matrix proteinases, MMP9 and MMP13, are mainly responsible for
the degradation of cartilage ECM. Mice deficient in either MMP9 or MMP13 have expanded
hypertrophic zones and delayed primary endochondral ossification due to impeded digestion
of ECM [15–17]. Interestingly, in Chkb−/− mice, MMP9 and MMP13 gene expression was
significantly reduced in both embryonic radius and ulna, as well as in primary chondrocytes
(Figs. 5A, B). The chondrocytes isolated from the radius and ulna of Chkb−/− mice also
exhibited diminished MMP9 activity in vitro (Fig. 5C). These data suggest that ECM
degradation is impaired in the radius and ulna of Chkb−/− mice, leading to slower
conversion of cartilage into bone.
Osteoclasts are also important for establishment of primary ossification. In the absence of
osteoclasts, cartilage ECM cannot be removed and there is no invasion by the ossification
front or bone deposition on cartilage remnants. TRAP staining revealed that the radius and
ulna of Chkb−/− mice recruit fewer osteoclasts to the cartilage/bone interface (Fig. 6),
indicating decreased cartilage resorption by osteoclasts. These findings further support the
conclusion that replacement of cartilage by bone in the radius and ulna is impaired in
Chkb−/− mice. Previous studies showed that MMPs, particularly MMP9, are necessary for
the migration of osteoclasts into hypertrophic cartilage during primary endochondral
ossification [51,52].
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4.3. Radius and ulna of Chkb−/− mice have impaired chondrocyte differentiation and
decreased chondrocyte proliferation
In addition to the defects in endochondral bone formation discussed above, we demonstrated
that the radius and ulna of Chkb−/− mice have impaired chondrocyte differentiation and
decreased proliferation since the expression of Sox9 and PCNA was reduced in the growth
plates (Figs. 4A, B, D, and E). Sox9 is an essential transcription factor that regulates the
differentiation of chondrocytes from mesenchymal cells during chondrogenesis [13,14].
Haplo-insufficiency of Sox9 in mice causes abnormalities in primordial cartilage including
bending of the radius and ulna [52]. The decreased expression of Sox9 in the radius and ulna
of embryonic Chkb−/− mice might be an important factor that contributes to the bending of
these bones. Moreover, a reduction in chondrocyte proliferation is consistent with the
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finding that bone lengths of the radius and ulna are reduced in Chkb−/− mice. Both CK and
its product PCho have been implicated in cell proliferation and transformation [53–56].
Production of PCho is an important event in growth factor-induced mitogenesis in
fibroblasts [57–59]. Moreover, increased CK activity has been detected in various cancer
cells, and an elevated PCho level has been used as a biomarker for tumor diagnosis [60–63].
The amount of PCho in chondrocytes from the radius and ulna of Chkb−/− mice was
significantly lower than in WT mice (Fig. 8C). Hence, the decrease in PCho might
contribute to the growth defects in radius and ulna of Chkb−/− mice.
4.4. Conjecture of radius and ulna specific deformations
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The reason why the bone deformities were restricted to radius and ulna in Chkb−/− mice, but
did not occur in other limb bones, is unclear. Our previous work on the muscular dystrophy
phenotype in Chkb−/− mice demonstrated that Chkb is the major CK isoform in the muscle
of hindlimb but not forelimb [64]. This finding provides an explanation for why the muscle
damage of Chkb−/− mice is more severe in the hindlimb than in the forelimb. Total CK
activity in chondrocytes isolated from all the limb long bones of Chkb−/− mice was ~80%
lower than in WT mice (Fig. 8B) suggesting that Chkb is the dominant isoform in
chondrocytes from all the limb long bones. This observation appears to eliminate the
possibility that the bone defects specifically in the radius and ulna are due to different
expression levels of the CK isoforms in the radius/ulna versus other limb long bones. In
addition, although our immunohistochemistry data for the humerus suggest that it has
normal chondrocyte differentiation and proliferation (Figs. 4C, F, G, and H), we haven’t
fully examined other events of its endochondral bone formation. Other limb long bones in
Chkb−/− mice including the humerus, tibia, and femur may have minor defects in some
aspects of endochondral ossification and growth plate physiology, which, however, are
probably not severe enough to induce the deformation. Perhaps, the unique anatomic feature
of murine radius and ulna, that is, being located in the distal forelimb as well as being
connected with each other to support the body weight, confer the fragility of deformity when
CKβ is absent.
4.5. Absence of CKβ in Chkb−/− mice only slightly decreases PC but significantly reduces
PCho in chondrocytes
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In order to determine whether or not Chkb deficiency affected the amounts of choline
metabolites and phospholipids in the cartilage of Chkb−/− mice, we isolated primary
chondrocytes and quantified these metabolites by mass spectrometry. The PC content of
chondrocytes from Chkb−/− mice was slightly lower than that of WT chondrocytes (Figs.
8D, F). This observation was not surprising since our previous studies have shown that the
PC content of most tissues of Chkb−/− mice was not altered [6]. Moreover, the rate-limiting
enzyme of the CDP-choline pathway for PC synthesis is CTP: phosphocholine
cytidylyltransferase, rather than CK [2,65]. Thus, the bone defects in Chkb−/− mice are
unlikely to be caused by a reduced content of PC. Nevertheless, the PCho content of
chondrocytes from Chkb−/− mice was dramatically reduced, suggesting that the deficiency
of PCho is more likely to be the cause of the bone defects (Figs. 8C, E). This reduction of
PCho was expected since most intracellular PCho is produced from CK [2,66].
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In addition to a role for PCho in cell proliferation, PCho has also been implicated in
regulating the function of Phospho1, a recently identified phosphatase that is expressed in
the mineralization surface of both bone and cartilage [67]. Phospho1 plays an important role
in skeletal calcification [68,69], and Phospho1 knockout mice have decreased bone mineral
density and deformed limb bones [70]. Phospho1 is a soluble cytosolic enzyme that has high
phosphohydrolase activity towards PCho and phosphoethanolamine [71,72]. PCho and
phosphoethanolamine are the two most abundant phospho-monoesters in cartilage [73]. CK
also phosphorylates ethanolamine to phosphoethanolamine [74,75]. Possibly Chkb
deficiency reduces the availability of substrates (PCho and phosphoethanolamine) for
Phospho1 and thereby limits the ability of Phospho1 to produce sufficient inorganic
phosphate (Pi) for cartilage mineralization. We observed that the amount of Phospho1
protein was higher in chondrocytes from Chkb−/− mice than in chondrocytes from WT mice
(Supplementary Fig. 3A) suggesting that a compensatory mechanism is activated in
response to lower substrate levels. Although the serum level of Pi is lower in Chkb−/− mice
than in WT mice, the Pi content of both embryonic bone tissues and primary chondrocytes
was not altered by CKβ deficiency (Supplementary Figs. 3D, E, F), suggesting that
chondrocytes from Chkb−/− mice have sufficient Pi for normal mineralization. Indeed, the
contribution of PCho and phosphoethanolamine to the total Pi pool is still unknown. Other
phosphorus-containing molecules such as ATP, ADP and pyrophosphate are also important
sources of Pi. All of these molecules are hydrolyzed by the major phosphatase in skeletal
tissue, the tissue non-specific alkaline phosphatase (TNAP) [76–78]. Our experiments
showed that TNAP activity in chondrocytes from Chkb−/− mice was the same as in WT
chondrocytes (Supplementary Fig. 3B). Furthermore, the staining and Micro-CT images of
skeletons did not reveal any obvious calcification defects in Chkb−/− mice (Fig. 1).
Therefore, we propose that the delay in cartilage mineralization in the radius and ulna of
Chkb−/− mice is primarily due to slower replacement of cartilage by bone rather than defects
in mineralization capability.
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Although the majority of PCho is produced by the CK reaction, some PCho (along with
ceramide) is generated from sphingomyelin by the neutral sphingomyelinase 2 (nSMase2),
which is encoded by the Smpd3 gene. Smpd3-deficient mice display dwarfism,
chondrodysplasia, limb bone deformation and abnormal embryonic growth plate phenotypes
[79–82]. These features are similar to those exhibited by Chkb−/− mice. In addition, Smpd3deficient mice also show severe hypomineralization pathology [79,82], which is not
observed in the Chkb−/− mice in this study. The role that PCho and/or ceramide plays in the
bone phenotypes of Smpd3-deficient mice is still unknown.
In conclusion, our data show that Chkb−/− mice have bone deformations specifically in the
radius and ulna and that these defects occur during late embryonic development. Chkb
deficiency in chondrocytes leads to a dramatic reduction in the amount of PCho but only a
slight decrease of PC. The radius and ulna of Chkb−/− mice have several defects in
endochondral bone formation including abnormal growth plate organization, decreased
chondrocyte differentiation and proliferation, impaired ECM degradation, reduced osteoclast
recruitment and delayed cartilage mineralization. These combined defects in cartilage
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development significantly contribute to the deformities of the radius and ulna. To our
knowledge this is the first study to demonstrate that Chkb plays an essential role in
endochondral bone formation, at least in the radius and ulna. Future studies on tissuespecific inactivation of Chkb, or even Chka, in cartilage, osteoblasts or osteoclasts are likely
to provide additional novel insights into the role of CK in normal endochondral bone
formation.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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choline kinase

DMEM

Dulbecco’s modified Eagle’s medium

ECM

extracellular matrix

FBS

fetal bovine serum

IGF-1

insulin-like growth factor 1

LC-MS

liquid chromatography-mass spectrometry

MMP

matrix metalloproteinase
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phosphatidylcholine

PCho

phosphocholine

PCNA

proliferating cell nuclear antigen

TNAP

tissue-nonspecific alkaline phosphatase

TRAP

tartrate-resistant acid phosphatase
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General Significance
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Our data indicate that choline kinase beta plays an important role in endochondral bone
formation by modulating growth plate physiology.
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Highlights
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•

We characterized the forelimb bone deformities in Chkb−/− mice.

•

The radius and ulna of Chkb−/− mice have abnormal growth plate physiology.

•

The radius and ulna of Chkb−/− mice have endochondral bone formation
defects.

•

Phosphocholine but not phosphatidylcholine is dramatically reduced in Chkb−/−
mice.
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Fig. 1.
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Deformation of the radius and ulna in Chkb−/− mice. Outward rotational forelimb bone
deformation was examined in P7 WT and Chkb−/− mice (A). Radius and ulna deformations
in P0 mice were visualized by skeletal staining of whole body (B) and forelimbs (C) with
Alizarin Red and Alcian Blue. Micro-CT imaging was performed on whole body (D) and
forelimbs (E). Severe deformation of the radius and ulna in 30-day-old Chkb−/− mice was
visualized by Micro-CT imaging (F). Red arrows indicate deformed radius and ulna in (B)
and (D).
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Fig. 2.
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Length of radius and ulna and bone deformation during embryonic development. Long
bones from newborn (P0) mice were dissected, stained with Alizarin Red and Alcian Blue
and the bone lengths were measured (A, C). Data in (A) are means ± SEM from 4 littermates
of each genotype; *: P < 0.05 compared to WT. Forelimbs were dissected free from soft
tissues. E13.5-E15.5 forelimbs were stained with Alcian Blue only whereas E17.5 forelimbs
were stained with both Alizarin Red and Alcian Blue.
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Fig. 3.
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Growth plate defects in the radius and ulna of Chkb−/− mice. P0 radius (A), P0 ulna (B),
E16.5 radius (E) and E16.5 ulna (F) were stained with Safranin O/fast green. The ratio of
hypertrophic zone (HZ) length / growth plate (GZ) length is shown in (C, D). Data in (C)
and (D) are means ± SEM from 3 littermates of each genotype; *: P < 0.05 compared to
WT.
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Fig. 4.

Chondrocyte differentiation and proliferation. Chondrocyte differentiation and proliferation
were examined in E15.5 embryonic bone growth plates of the radius (A, D), ulna (B, E) and
humerus (C, F) of Chkb−/− and WT mice by Sox9 (A, B, C) and PCNA (D, E, F)
immunohistochemistry. The percentage of positively stained cells was quantified (G, H).
Data are means ± SEM from 3–4 littermates of each genotype; *: P < 0.05 compared to WT.
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Fig. 5.

mRNA levels and activity of MMPs in the radius and ulna. mRNA levels of MMP9 and
MMP13 were analyzed in the radius and ulna of embryonic bone tissues (A) and E15.5
primary chondrocytes (B) of Chkb−/− and WT mice by quantitative real-time PCR. Data are
means ± SEM from 3 littermates of each genotype; *: P < 0.05 compared to WT. (C):
MMP9 activity was measured in primary chondrocytes from Chkb−/− and WT mice. Gel
shows the presence of the proform and the mature form in the gelatin zymography assay.
Minus = distilled water (negative control); plus = proteins from the chondrogenic cell line
ATDC5 (positive control).

NIH-PA Author Manuscript
Biochim Biophys Acta. Author manuscript; available in PMC 2015 July 01.

Li et al.

Page 25

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Fig. 6.
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The radius and ulna of Chkb−/− mice contain fewer osteoclasts along the chondro-osseous
junction. Bone sections from the radius (A, C) and ulna (B, D) of 7-day-old WT (A and B)
and Chkb−/− (C and D) mice were stained for the osteoclast marker, tartrate-resistant acid
phosphatase (TRAP). Arrows show dark purple TRAP-positive cells. The number of TRAPpositive foci was quantified along the cartilage/bone interface (E, F). Data are means ± SEM
from 3 littermates of each genotype; *: P < 0.05 compared to WT.
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Fig. 7.

Formation of the primary ossification center in the radius and ulna. To evaluate formation of
the primary ossification center, radius bones (A, C) and ulna bones (B, D) from E15.5 WT
(A, B) and Chkb−/− (C, D) mice were stained by the von Kossa method. Dark stain indicates
mineralized bone.
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Fig. 8.
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Biochemical analyses of primary chondrocytes. E15.5 bones were dissected free of soft
tissue and primary chondrocytes were isolated for immunoblotting of CKβ (A), CK
enzymatic activity (B), and quantification of choline metabolites (C, E) and phospholipids
(D, F) by mass spectrometry. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS,
phosphatidylserine; PI, phosphatidylinositol; SM, sphingomyelin. Data in B-F are means ±
SEM from 3 littermates of each genotype; *: P < 0.05 compared to WT.
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